Kuros Biosciences AG (SWX:KURN)

Market Cap	1.02B
Revenue (ttm)	75.56M
Net Income (ttm)	-4.29M
Shares Out	38.37M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	253.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	578,036
Average Volume	241,453
Open	28.04
Previous Close	26.58
Day's Range	25.80 - 28.70
52-Week Range	11.92 - 32.00
Beta	0.69
RSI	42.69
Earnings Date	Aug 14, 2025

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bon...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 122
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

In 2024, Kuros Biosciences AG's revenue was 75.56 million, an increase of 125.11% compared to the previous year's 33.56 million. Losses were -4.29 million, -68.75% less than in 2023.